Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::425402956.png) @pick1998_2 Nick zheng

Nick zheng posts on X about $vstm, aav, $srpt, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::425402956/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX +202%
- X Months XXXXXX +382%
- X Year XXXXXX -XX%

### Mentions: X [#](/creator/twitter::425402956/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:posts_active.svg)

- X Week X +29%
- X Month XX +50%
- X Months XX +600%
- X Year XX no change

### Followers: XXXXX [#](/creator/twitter::425402956/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:followers.svg)

- X Week XXXXX +0.42%
- X Month XXXXX +1.50%
- X Months XXXXX +4.50%
- X Year XXXXX +6.10%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::425402956/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::425402956/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::425402956/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$vstm](/topic/$vstm) 5.56%, [aav](/topic/aav) 2.78%, [$srpt](/topic/$srpt) 2.78%, [discount](/topic/discount) 2.78%, [$mreo](/topic/$mreo) 2.78%, [drugs](/topic/drugs) 2.78%, [stocks](/topic/stocks) 2.78%, [$urgn](/topic/$urgn) 2.78%, [c3](/topic/c3) 2.78%, [$apls](/topic/$apls) XXXX%

**Top accounts mentioned or mentioned by**
[@fireworkstrades](/creator/undefined) [@nolastevedore](/creator/undefined) [@achillestxcom](/creator/undefined) [@melvinriskmgmt](/creator/undefined) [@lramseu](/creator/undefined) [@ej23ny](/creator/undefined) [@buffalo51766917](/creator/undefined) [@stocksdd](/creator/undefined) [@ravi1982nl](/creator/undefined)

**Top assets mentioned**
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls)
### Top Social Posts [#](/creator/twitter::425402956/posts)
---
Top posts by engagements in the last XX hours

"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1945600798219800844) 2025-07-16 21:45:52 UTC 6922 followers, 7126 engagements


"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1944774197437448259) 2025-07-14 15:01:15 UTC 6921 followers, 3831 engagements


"$VSTM $URGN keep adding these two cheap biotech stocks with unique approved drugs for specific cancers"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1940816161412886577) 2025-07-03 16:53:26 UTC 6922 followers, 1721 engagements


"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"  
![@pick1998_2 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::425402956.png) [@pick1998_2](/creator/x/pick1998_2) on [X](/post/tweet/1946231638557618231) 2025-07-18 15:32:36 UTC 6910 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@pick1998_2 Avatar @pick1998_2 Nick zheng

Nick zheng posts on X about $vstm, aav, $srpt, discount the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX +202%
  • X Months XXXXXX +382%
  • X Year XXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Week X +29%
  • X Month XX +50%
  • X Months XX +600%
  • X Year XX no change

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.42%
  • X Month XXXXX +1.50%
  • X Months XXXXX +4.50%
  • X Year XXXXX +6.10%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX%

Social topic influence $vstm 5.56%, aav 2.78%, $srpt 2.78%, discount 2.78%, $mreo 2.78%, drugs 2.78%, stocks 2.78%, $urgn 2.78%, c3 2.78%, $apls XXXX%

Top accounts mentioned or mentioned by @fireworkstrades @nolastevedore @achillestxcom @melvinriskmgmt @lramseu @ej23ny @buffalo51766917 @stocksdd @ravi1982nl

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Top Social Posts #


Top posts by engagements in the last XX hours

"$SRPT pivoting from AAV gene therapy/RNA splicing to siRNA therapies and broadened applications. A good direction. strong buy under 30"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-16 21:45:52 UTC 6922 followers, 7126 engagements

"$MREO buy it now at XX% discount and forget it for a few months. Very likely it will recover when topline final data are announced by end of this year"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-14 15:01:15 UTC 6921 followers, 3831 engagements

"$VSTM $URGN keep adding these two cheap biotech stocks with unique approved drugs for specific cancers"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-03 16:53:26 UTC 6922 followers, 1721 engagements

"$APLS PUDFA 7/28/25 sNDA of EMPAVELI(pegcetacoplan) for C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) which are severe and rare kidney diseases. Priority Review. Approval should come. It should help reach profitability"
@pick1998_2 Avatar @pick1998_2 on X 2025-07-18 15:32:36 UTC 6910 followers, XXX engagements

@pick1998_2
/creator/twitter::pick1998_2